Kange Corp. (KGNR)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Kange Corp. (KGNR) trades at $2.20 with AI Score 44/100 (Grade C). Kange Corp. develops and markets mobile software applications, focusing on technology-based health treatments for mental health conditions. Market cap: $199.15M, Sector: Technology.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for KGNR: KGNR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KGNR against Technology peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
KGNR: the 1 perspectives are evenly split.
How is this calculated? →Kange Corp. (KGNR) Technology Profile & Competitive Position
Kange Corp. is a technology company specializing in mobile application development, with a focus on creating software for mental health treatments. Operating in the application software industry, Kange Corp. aims to address conditions like autism, dementia, Alzheimer's, and PTSD through its technology-based solutions, setting it apart in a competitive market.
What Is the Investment Thesis for KGNR?
Kange Corp. presents a speculative investment opportunity within the technology sector, specifically in the application software industry focused on mental health. The company's focus on developing mobile applications for conditions like autism, dementia, Alzheimer's, and PTSD positions it in a niche market with potential for growth. However, with a negative P/E ratio of -1369.43, profitability is a concern. The company's extremely high profit margin of 2157837.5% may be an anomaly or the result of specific accounting practices that require further investigation. Key catalysts include successful development and marketing of new applications, partnerships with healthcare providers, and positive clinical outcomes demonstrating the effectiveness of its technology-based treatments. The negative beta of -0.80 suggests the stock price moves inversely to the market, offering some potential diversification benefits. Investors should carefully assess the company's financial stability, competitive landscape, and ability to execute its business plan before investing.
Based on FMP financials and quantitative analysis
KGNR Key Highlights
- Market Cap of $199.15M indicates a small-cap company with potential for growth but also higher risk.
- P/E Ratio of -1369.43 suggests the company is not currently profitable, requiring further investigation into its financial performance.
- Profit Margin of 2157837.5% is exceptionally high and warrants scrutiny to ensure accuracy and sustainability.
- Beta of -0.80 indicates the stock price has historically moved inversely to the market, potentially offering diversification benefits.
- No Dividend Yield reflects that the company is not currently returning profits to shareholders, which is common for growth-oriented companies.
Who Are KGNR's Competitors?
KGNR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVNF Alviva Holdings Limited | $1.54 | +0.00% | $167.69M | 55 |
| BTGHF Bigtincan Holdings Limited | $0.13 | +0.00% | $112.45M | 50 |
| CBSZF Cybernet Systems Co., Ltd. | $4.93 | -30.56% | $152.34M | 43 |
| DAHLF Damstra Holdings Limited | $0.84 | +0.00% | $216.46M | 42 |
| DOTDF dotdigital Group Plc | $0.56 | -0.01% | $169.10M | 53 |
| NOW ServiceNow, Inc. | $108.69 | +2.23% | $112.09B | 71 |
| RSASF RESAAS Services Inc. | $0.30 | +2.76% | $25.04M | 69 |
| CSAI Cloudastructure Inc. | $0.36 | +0.47% | $6.84M | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KGNR's Key Strengths?
- Focus on mobile applications for mental health.
- Potential for high profit margins.
- Negative beta suggests potential diversification benefits.
- Addresses a growing market need for mental health solutions.
What Are KGNR's Weaknesses?
- Lack of profitability (negative P/E ratio).
- Small market capitalization increases volatility.
- Limited information available on the company's operations.
- Dependence on successful development and marketing of applications.
What Could Drive KGNR Stock Higher?
- Successful development and launch of new mobile applications for mental health.
- Partnerships with healthcare providers to integrate Kange Corp.'s applications into treatment programs.
- Positive clinical outcomes demonstrating the effectiveness of Kange Corp.'s technology-based treatments.
- Expansion into international markets with localized versions of its applications.
- Development and integration of AI-powered features to enhance application functionality.
What Are the Key Risks for KGNR?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Competition from established technology companies and healthcare providers.
- Regulatory changes in the healthcare industry affecting mobile health applications.
- Rapid technological advancements rendering Kange Corp.'s applications obsolete.
- Negative clinical outcomes or user feedback impacting the reputation of its applications.
- Limited financial resources and potential difficulty in securing funding for future growth.
What Are the Growth Opportunities for KGNR?
- Expansion into New Mental Health Applications: Kange Corp. has the opportunity to develop and market new mobile applications targeting a broader range of mental health conditions. This could include applications for anxiety, depression, and other common mental health disorders. The global market for mental health applications is projected to reach $17.6 billion by 2027, representing a significant growth opportunity for the company. Timeline: Within the next 2-3 years.
- Partnerships with Healthcare Providers: Kange Corp. can pursue strategic partnerships with healthcare providers, such as hospitals, clinics, and mental health organizations. These partnerships could involve integrating Kange Corp.'s applications into existing treatment programs and offering them to patients as part of their care. This would provide the company with access to a larger customer base and enhance its credibility within the healthcare industry. Timeline: Ongoing.
- International Market Expansion: Kange Corp. can expand its operations into international markets, targeting countries with a growing demand for mental health solutions. This could involve adapting its applications to different languages and cultures, as well as establishing partnerships with local healthcare providers and distributors. The global market for mental health services is expanding, creating opportunities for Kange Corp. to reach new customers and increase its revenue. Timeline: Within the next 3-5 years.
- Development of AI-Powered Features: Kange Corp. can invest in the development of artificial intelligence (AI) powered features for its mobile applications. This could include using AI to personalize treatment plans, provide real-time feedback to users, and predict potential mental health crises. AI-powered mental health solutions are gaining traction, offering the potential to improve the effectiveness and accessibility of mental healthcare. Timeline: Ongoing.
- Integration with Wearable Technology: Kange Corp. can integrate its mobile applications with wearable technology, such as smartwatches and fitness trackers. This would allow the company to collect real-time data on users' physical and mental health, providing valuable insights for personalized treatment plans. The market for wearable technology is growing rapidly, creating opportunities for Kange Corp. to enhance its applications and improve user engagement. Timeline: Within the next 2-3 years.
What Opportunities Does KGNR Have?
- Expansion into new mental health conditions.
- Partnerships with healthcare providers.
- International market expansion.
- Development of AI-powered features.
What Threats Does KGNR Face?
- Competition from established technology companies.
- Regulatory changes in the healthcare industry.
- Rapid technological advancements.
- Potential for negative clinical outcomes.
What Are KGNR's Competitive Advantages?
- Specialized Focus: Kange Corp.'s focus on specific mental health conditions creates a niche market position.
- Technology-Based Solutions: The company's emphasis on mobile applications provides a competitive advantage.
- Potential for Innovation: Continuous development of new applications and features can strengthen its moat.
- Partnerships: Collaborations with healthcare providers can enhance market reach and credibility.
What Does KGNR Do?
Kange Corp., incorporated in 2013 and headquartered in Studio City, California, is a technology company focused on the development and marketing of mobile software products as mobile applications for end-users. The company's primary focus is on providing technology and holistic technology-based health treatments for various mental health conditions. These conditions include autism, dementia, Alzheimer's, and PTSD. Kange Corp. aims to leverage mobile technology to deliver accessible and innovative solutions for individuals and caregivers dealing with these challenging conditions. The company's business model centers around creating and distributing mobile applications that offer therapeutic and supportive tools. These applications are designed to assist in managing symptoms, improving cognitive function, and enhancing the overall quality of life for individuals affected by mental health disorders. Kange Corp. operates within the application software industry, a sector characterized by rapid innovation and evolving user needs. The company's success depends on its ability to develop effective and user-friendly applications that meet the specific requirements of its target audience. Kange Corp. faces competition from other technology companies and healthcare providers in the mental health space. The company differentiates itself by focusing on mobile solutions and integrating technology with holistic treatment approaches.
What Products and Services Does KGNR Offer?
- Develop mobile software applications for end-users.
- Focus on technology-based health treatments.
- Target mental health conditions such as autism, dementia, and Alzheimer's.
- Offer solutions for PTSD.
- Create applications designed to manage symptoms of mental health conditions.
- Improve cognitive function through mobile technology.
- Enhance the overall quality of life for individuals affected by mental health disorders.
How Does KGNR Make Money?
- Develop and market mobile applications for mental health treatments.
- Generate revenue through app sales and subscriptions.
- Potentially explore partnerships with healthcare providers for distribution.
- Focus on technology-based solutions for specific mental health conditions.
What Industry Does KGNR Operate In?
Kange Corp. operates within the application software industry, a dynamic sector driven by technological innovation and evolving consumer needs. The market for mobile health applications is experiencing significant growth, fueled by increasing awareness of mental health issues and the adoption of digital health solutions. Kange Corp.'s focus on technology-based treatments for conditions like autism, dementia, and Alzheimer's positions it within a specialized segment of this market. Competitors include other software developers, healthcare providers, and technology companies offering mental health solutions. The company's success depends on its ability to differentiate itself through innovative applications and effective marketing strategies.
Who Are KGNR's Key Customers?
- Individuals with autism, dementia, Alzheimer's, and PTSD.
- Caregivers of individuals with these conditions.
- Healthcare providers seeking technology-based treatment solutions.
- End-users looking for mobile applications to manage mental health.
How Kange Corp. Is Valued
Kange Corp. carries a market capitalization of $199.15M, placing it in the micro-cap category. Relative to its peer group, KGNR's quantitative score of 44/100 is roughly in line with the peer average of 49/100.
ROE 180%Key Financial Metrics
Return on equity for Kange Corp. stands at 179.6%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.5%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 2/9Financial Health
Kange Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
KGNR Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Focus on mobile applications for mental health.
- Potential for high profit margins.
- Negative beta suggests potential diversification benefits.
- Addresses a growing market need for mental health solutions.
Bear Case
- Lack of profitability (negative P/E ratio).
- Small market capitalization increases volatility.
- Limited information available on the company's operations.
- Dependence on successful development and marketing of applications.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
KGNR Latest News
No recent news available for KGNR.
KGNR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KGNR.
Price Targets
Wall Street price target analysis for KGNR.
KGNR MoonshotScore
What does this score mean?
The MoonshotScore rates KGNR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Arthur Malone Jr.
CEO
Arthur Malone Jr. serves as the CEO of Kange Corp. Information regarding his prior experience and educational background is not available. As CEO, he is responsible for overseeing the company's strategic direction, operations, and financial performance. His leadership is crucial to Kange Corp.'s success in the competitive technology and mental health sectors. Further information on his specific qualifications and expertise would provide a more comprehensive assessment of his capabilities.
Track Record: Due to limited information available, it is difficult to assess Arthur Malone Jr.'s track record at Kange Corp. or in previous roles. Key milestones and strategic decisions under his leadership are not readily accessible. A more detailed analysis of his accomplishments and contributions would be necessary to evaluate his effectiveness as CEO.
KGNR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Kange Corp. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater risks. Investing in OTC Other stocks carries significant risks due to the potential for fraud, lack of liquidity, and limited regulatory oversight. Investors should exercise extreme caution and conduct thorough due diligence before investing in companies on this tier. These companies are not required to be SEC reporting.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: Lack of readily available financial information increases investment risk.
- Low Liquidity: Potential difficulty in buying or selling shares at desired prices.
- Price Volatility: Susceptibility to significant price swings due to limited trading volume.
- Regulatory Scrutiny: Increased risk of regulatory action due to non-compliance with reporting requirements.
- Potential for Fraud: Higher risk of fraudulent activity due to limited oversight.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Company's stated focus on developing mobile applications for mental health.
- Headquarters located in Studio City, California.
- Existence of a CEO, Arthur Malone Jr.
- Incorporation date of 2013 suggests some operating history.
- Focus on technology and holistic technology-based health treatments
KGNR Technology Stock FAQ
What does Kange Corp. do?
Kange Corp. develops and markets mobile software applications focused on technology-based health treatments for mental health conditions. The company's primary focus is on creating applications for conditions such as autism, dementia, Alzheimer's, and PTSD. These applications are designed to assist in managing symptoms, improving cognitive function, and enhancing the overall quality of life for individuals affected by these conditions. Kange Corp. aims to leverage mobile technology to deliver accessible and innovative solutions within the mental health space.
What do analysts say about KGNR stock?
Analyst coverage of KGNR stock is currently limited due to its OTC Other listing and small market capitalization. Key valuation metrics, such as the negative P/E ratio of -1369.43, suggest the company is not currently profitable. Growth considerations include the potential for expansion into new mental health conditions and partnerships with healthcare providers. Investors should conduct thorough due diligence and consider the risks associated with investing in OTC stocks before making any investment decisions. There is no current consensus rating available.
What are the main risks for KGNR?
The main risks for Kange Corp. include competition from established technology companies and healthcare providers, regulatory changes in the healthcare industry, and the potential for rapid technological advancements. The company's limited financial resources and dependence on successful development and marketing of applications also pose significant risks. Additionally, as an OTC Other stock, KGNR is subject to increased price volatility, low liquidity, and potential for fraud. Investors should carefully consider these risks before investing in Kange Corp.
What are the key factors to evaluate for KGNR?
Kange Corp. (KGNR) holds an AI score of 44/100 (low). Not financial advice.
How frequently does KGNR data refresh on this page?
KGNR prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven KGNR's recent stock price performance?
Kange Corp. (KGNR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on mobile applications for mental health. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KGNR overvalued or undervalued right now?
Valuing Kange Corp. (KGNR) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying KGNR?
Before investing in Kange Corp. (KGNR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's operations and financial performance.
- OTC Other listing increases investment risk.
- AI analysis pending for KGNR